 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Theranostics Health to Launch Breast Cancer Dx in Early 2013, Raise $5M to $10M in Funding
June 15, 2012
Theranostics Health to Launch Breast Cancer Dx in Early 2013, Raise $5M to $10M in Funding
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor - Theranostics Looks for Med Fusion Deal to Aid in Clinical Validation, Payor Access
August 31, 2012 / ProteoMonitor - GMU's Petricoin Building Database That Details Activation in Cancer Protein Pathways
August 13, 2010 / ProteoMonitor - Theranostics Health Launching Alternative to Formalin for Preserving Phosphoproteomic Tissue Samples
September 2, 2011 / ProteoMonitor - TCGA Breast Cancer Study Demonstrates Benefits of Integrating Genomic, Proteomic Data
September 28, 2012 / ProteoMonitor